Exhibitors Search
진큐어
Booth no.
A60
|
Exhibition
|
| |
|---|---|
|
Country
|
| Korea, South |
|
Address
|
| |
|
Tel
|
|-- |
|
Exhibits
|
| Lsosome activation plays the key role in the pathogenesis of neurodegenerative diseases |
|
Company Type
|
| |
Exhibitor Information
ZINCURE is a Biotech Company Developing Therapies for Acute and Degenerative Brain Diseases Through Zinc Homeostasis Regulation.
Our lead program focuses on a therapeutic candidate for Amyotrophic Lateral Sclerosis (ALS), while expanding into broader neurodegenerative disease areas.
Our lead program focuses on a therapeutic candidate for Amyotrophic Lateral Sclerosis (ALS), while expanding into broader neurodegenerative disease areas.
Exhibit/Technology Introduction (General)
Development of a treatment for Lou Gehrig's disease using a lysosome function activator
Individual Exhibit/Technology Introduction (Detailed)
-
Product Name : ysosome may play the key role in the pathogenesis of neurodegenerative diseasesysosome may play the key role in the pathogenesis of neurodegenerative diseases
KYUNGYON EXHIBITION CORP.
